Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1
Our investigations validate a DRLR-based risk scoring model as an effective prognostic tool for Asian HCC. This model not only enhances understanding of disulfidptosis's role in HCC but also facilitates personalised treatment strategies, potentially improving patient outcomes.
Authors
- Ling Sha (ORCID: https://orcid.org/0000-0002-5394-6575)
- Duo Shen (ORCID: https://orcid.org/0000-0002-2715-1090)
- Xuefeng Gu (ORCID: https://orcid.org/0000-0002-6198-2568)
- Yang Ling (ORCID: https://orcid.org/0000-0001-5970-8407)
Institutions
- Jiangsu University (CN)
- Nanjing Drum Tower Hospital (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Changzhou No.2 People's Hospital (CN)
- Changzhou Third People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1007/s12672-025-02325-5
- Citations
- 4
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- Nanjing University
- Nanjing Drum Tower Hospital